Thiazide Diuretics

Thiazides act one segment past the loops, at the distal convoluted tubule (DCT), where they block the Na-Cl cotransporter (NCC). This segment only reclaims about 3–5% of filtered sodium, so thiazides are mild-to-moderate diuretics — nowhere near the "high-ceiling" power of loops. Yet they are the first-line drug for hypertension, and understanding why reveals something about blood pressure. Early on, they lower pressure by shedding sodium and volume; but over weeks the volume partly normalizes and the pressure stays down because of a reduction in peripheral vascular resistance (the vessels relax). So a modest diuretic becomes a durable antihypertensive.

Two practical facts shape their use. First, thiazides lose their effect when kidney function is poor — generally useless below a GFR of about 30 mL/min — which is the opposite of loops and the reason loops take over in advanced CKD. The exceptions are thiazide-like agents — metolazone (and chlorthalidone and indapamide) keep working at low GFR — and metolazone is deliberately combined with a loop to break through resistant, refractory edema. Second, agents differ in strength and duration: chlorthalidone is longer-acting and more potent than hydrochlorothiazide (HCTZ), a distinction that matters for 24-hour blood-pressure control.

Thiazides carry a distinctive metabolic fingerprint made of four metabolic highs: hyperglycemia, hyperlipidemia, hyperuricemia (gout), and hypercalcemia. Alongside those “highs” come the classic diuretic “lows” — hypokalemia and a hypokalemic metabolic alkalosis (from the same increased distal sodium-for-potassium exchange seen with loops), hyponatremia, and hypomagnesemia. The hyponatremia deserves special emphasis: it is a genuinely common and sometimes dangerous thiazide effect, especially in older women, and can present as confusion.

The one to lock in is the calcium contrast. Loops increase urinary calcium excretion; thiazides reduce it — less calcium reaches the urine, and serum calcium can rise (hypercalcemia). This is not just trivia: it is why thiazides are used to prevent calcium kidney stones (less calcium in the urine) and are considered gentle on bone. So the two classes have opposite effects on urinary calcium, and that one contrast keeps the whole metabolic picture organized.

Each caution traces to that fingerprint. Hypokalemia again threatens arrhythmias and digoxin toxicity, so potassium is monitored and replaced. The rise in glucose matters in diabetes, the rise in uric acid can trigger a gout flare, and the drop in sodium (with confusion risk in the elderly) warrants checking. Thiazides are sulfonamide derivatives, so the label contraindicates them in sulfonamide-drug hypersensitivity — though true cross-reactivity with sulfa antibiotics is considered low. And two interactions stand out: thiazides reduce lithium clearance (toward toxicity) and, via hypokalemia, sensitize the heart to digoxin.

The nursing plan writes itself from the fingerprint. Monitor potassium, sodium, glucose, uric acid, and calcium, take the drug in the morning, and use orthostatic precautions. Encourage potassium-rich foods, and counsel awareness of gout and blood sugar. Because thiazides are photosensitizing (and carry a small skin-cancer signal), advise sun protection. As with the loops, the Cardiovascular section’s Diuretics class covers these same drugs from the blood-pressure and heart-failure angle — here the emphasis is the nephron, the electrolytes, and the CKD limit. There is no boxed warning for the class.